Matthew Ziegler, MD, MSCE
Assistant Professor of Medicine (Infectious Diseases) at the Hospital of the University of Pennsylvania
Attending Physician, Hospital of the University of Pennsylvania
Attending Physician, Penn Presbyterian Medical Center
Faculty-Fellow, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Senior Scholar, Center for Clinical Epidemiology and Biostatics
Associate Healthcare Epidemiologist, Hospital of the University of Pennsylvania
Department: Medicine
Contact information
3 Silverstein Pavilion, 3400 Spruce Street
Philadelphia, PA 19104
Philadelphia, PA 19104
Email:
mattz@pennmedicine.upenn.edu
mattz@pennmedicine.upenn.edu
Publications
Education:
BA (Biology)
Saint Louis University, 2008.
MD
University of Wisconsin School of Medicine, 2012.
MS (Clinical Epidemiology)
University of Pennsylvania, 2018.
Permanent linkBA (Biology)
Saint Louis University, 2008.
MD
University of Wisconsin School of Medicine, 2012.
MS (Clinical Epidemiology)
University of Pennsylvania, 2018.
Description of Clinical Expertise
Infectious diseases in patients with hematologic malignancy.Description of Research Expertise
Healthcare-associated infections in patients with hematologic malignancy.Transmission of multi-drug resistant organisms within the hospital environment.
Selected Publications
18. Lazarow H, Compher CW, Ziegler MJ, Gilmar C, Freyer C, Kucharczuk C, Landsburg DJ: Central-line associated bloodstream infection in malignant hematology patients receiving parenteral nutrition. Manuscript Accepted for Publication. Journal of Parenteral and Enteral Nutrition, 2023.Ziegler MJ, Flores EJ, Epps M, Hopkins K, Glaser L, Mull NK, Pegues DA. : Clostridioides difficile Dynamic Electronic Order Panel, an Effective Automated Intervention to Reduce Inappropriate Inpatient Ordering. Manuscript Accepted for Publication. Infection Control & Hospital Epidemiology 2023.
Hartman RE, Feyer CW, Carulli A, Pegues D, Ziegler MJ, Loren AW: Levofloxacin prophylaxis reduces the incidence of pre-engraftment gram-negative bacteremia in myeloablative allogeneic hematopoietic cell transplant. Manuscript under Review 2023.
Ziegler MJ, Babcock HH, Welbel SF, Warren DK, Trick WE, Tolomeo P, Omorogbe J, Garcia D, Habrock-Bach T, Donceras O, Gaynes S, Cressman L, Burnham JP, Bilker W, Reddy SC, Pegues D, Lautenbach E, Kelly BJ, Fuchs B, Martin ND, Han JH.: Stopping Hospital Infections With Environmental Services (SHINE): A Cluster-randomized Trial of Intensive Monitoring Methods for Terminal Room Cleaning on Rates of Multidrug-resistant Organisms in the Intensive Care Unit. Clin Infect Dis 75: 1217-1223, Sep 2022.
Kim KN, LaRiviere M, Macduffie E, White CA, Jordan-Luft MM, Anderson E, Ziegler M, Radcliff JA, Jones J.: Use of Glucocorticoids in Patients With Cancer: Potential Benefits, Harms, and Practical Considerations for Clinical Practice. Pract Radiat Oncol Jul 2022.
Zhang HL, Kelly BJ, David MZ, Lautenbach E, Huang E, Bekele S, Tolomeo P, Reesey E, Loughrey S, Pegues D, Ziegler MJ; CDC Prevention Epicenters Program.: SARS-CoV-2 RNA persists on surfaces following terminal disinfection of COVID-19 hospital isolation rooms. Am J Infect Control 2022.
Ziegler MJ, Huang E, Bekele S, Reesey E, Tolomeo P, Loughrey S, David MZ, Lautenbach E, Kelly BJ; CDC Prevention Epicenters Program.: Spatial and temporal effects on severe acute respiratory coronavirus virus 2 (SARS-CoV-2) contamination of the healthcare environment. Infect Control Hosp Epidemiol Dec 2021.
Zhang HL, Kelly BJ, David MZ, Lautenbach E, Huang E, Bekele S, Tolomeo P, Reesey E, Loughrey S, Pegues D, Ziegler MJ; CDC Prevention Epicenters Program.: Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) surface contamination in staff common areas and impact on healthcare worker infection: Prospective surveillance during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol Nov 2021.
Kelly BJ, Bekele S, Loughrey S, Huang E, Tolomeo P, David MZ, Lautenbach E, Han JH, Ziegler MJ; CDC Prevention Epicenters Program.: Healthcare microenvironments define multidrug-resistant organism persistence. Infect Control Hosp Epidemiol Aug 2021.
Mody L, Akinboyo IC, Babcock HM, Bischoff WE, Cheng VC, Chiotos K, Claeys KC, Coffey KC, Diekema DJ, Donskey CJ, Ellingson KD, Gilmartin HM, Gohil SK, Harris AD, Keller SC, Klein EY, Krein SL, Kwon JH, Lauring AS, Livorsi DJ, Lofgren ET, Merrill K, Milstone AM, Monsees EA, Morgan DJ, Perri LP, Pfeiffer CD, Rock C, Saint S, Sickbert-Bennett E, Skelton F, Suda KJ, Talbot TR, Vaughn VM, Weber DJ, Wiemken TL, Yassin MH, Ziegler MJ, Anderson DJ; SHEA Research Committee.: Coronavirus disease 2019 (COVID-19) research agenda for healthcare epidemiology. Infect Control Hosp Epidemiol Jan 2021.